Composition
- Active ingredients
- OXACILLIN SODIUM EQ 500MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- OXACILLIN SODIUM EQ 500MG BASE · CapsuleANDA062241-002 · Discontinued
- OXACILLIN SODIUM EQ 250MG BASE · CapsuleANDA062241-001 · Discontinued
- OXACILLIN SODIUM EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableANDA061334-009 · Discontinued
- OXACILLIN SODIUM EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableANDA061334-007 · Discontinued
- OXACILLIN SODIUM EQ 4GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableANDA061334-008 · Discontinued
- OXACILLIN SODIUM EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableANDA061334-006 · Discontinued
- OXACILLIN SODIUM EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableANDA061334-010 · Discontinued
- OXACILLIN SODIUM EQ 250MG BASE/5ML · For solutionANDA062321-001 · Discontinued
- OXACILLIN SODIUM EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable
At a glance
- Brand name
- Bactocill
- Active substance
- oxacillin sodium
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 27 Jul 1973
- Application
- ANDA061336-002